Testing effectiveness (Phase 2)Study completedNCT05536804
What this trial is testing
Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Who this might be right for
OverweightObesityChronic Kidney Disease+2 more
Eli Lilly and Company 134